Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients-Reference-Cited by-同舟云学术

Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients

Published:2000-10 Issue:7 Volume:33 Page:557-562
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Salm Paul,Rutherford David M,Taylor Paul J,Black Marion J,Pillans Peter I

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference25 articles.

1. A prospective trial of tacrolimus (FK506) in clinical heart transplantation;Pham;J Thorac Cardiovasc Surg,1996

2. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation;Mentzer;Transplantation,1998

3. A prospective randomized trial of FK506 versus cyclosporin after human pulmonary transplantation;Griffith;Transplantation,1994

4. Tacrolimus (FK506) as primary immunosuppressant after lung transplantation;Kur;Thorac Cardiovasc Surg,1999

5. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation;Spencer;Drugs,1997

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report;Transplantation Proceedings;2022-07

2. Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients;American Journal of Health-System Pharmacy;2019-11-07

3. Association of Whole Blood Tacrolimus Concentrations with Kidney Injury in Heart Transplantation Patients;EUR J DRUG METAB PH;2018

4. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service;Clinical Biochemistry;2016-09

5. Tandem MS: It's now the norm;Clinical Biochemistry;2015-01